NEFL and ovarian cancer: Other studies have suggested that NfL levels are a valuable biomarker of neuroaxonal injury in chemotherapy-induced peripheral neuropathy, which occurs mainly when paclitaxel is used to treat breast and ovarian cancer.21,43,44 We were unable to demonstrate the same correlation in our study.